Chanez is lead for global Pharmacovigilance at Canopy Growth, the world’s largest cannabis company. With over 15 years of experience in Global and Canadian PV, she holds a bachelor’s degree in microbiology and immunology from Université de Montréal and a MBA from HEC Montréal. Chanez started her career at ratiopharm Inc. and Axcan Pharma; she later joined Mallinckrodt Pharmaceuticals as head of Canadian PV where she also led global integration and migration projects. Chanez co-chaired the Canadian Annual DIA meeting in 2013 and remained a contributor for several years.

Rita Cassola is an Executive Director of Pharmacovigilance at Certus PV Services Inc. Rita is a registered pharmacist with over 20 years of experience in global and Canadian pharmacovigilance. Rita’s experience includes over 10 years of senior PV consultancy and 10 years in increasingly senior PV roles within the pharmaceutical industry. Prior to joining the pharmaceutical industry, Rita spent 4 years in academia and 10 years in hospital pharmacy. Rita is engaged in teaching pharmacovigilance courses and has presented at several conferences/webinars organized by professional associations.

Dr. Rania Mouchantaf is A/Executive Director at the Marketed Health Products Directorate at Health Canada with over 17 years of experience in the area of pharmacovigilance. Before entering the public service she worked in the private sector, however her interest in pharmacovigilance and public health led her to join the federal government at Health Canada where she has assumed different roles in assessment, management and strategic policy development from both a pre and post market perspective in the area of safety, efficacy and quality Her education includes a Bachelor degree in Microbiology and Immunology and a doctorate degree in Pharmacology and Therapeutics from McGill University.